Insight Molecular Diagnostics Inc.
IMDX
$5.34
-$0.18-3.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 260.00K | 518.00K | 2.14M | 1.49M | 115.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 260.00K | 518.00K | 2.14M | 1.49M | 115.00K |
| Cost of Revenue | 121.00K | 168.00K | 806.00K | 869.00K | 43.00K |
| Gross Profit | 139.00K | 350.00K | 1.33M | 617.00K | 72.00K |
| SG&A Expenses | 3.93M | 4.11M | 4.32M | 3.76M | 3.61M |
| Depreciation & Amortization | -- | -- | 7.00K | 22.00K | 22.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.93M | 7.56M | 7.98M | 6.91M | 6.49M |
| Operating Income | -7.67M | -7.04M | -5.84M | -5.42M | -6.38M |
| Income Before Tax | -10.85M | -9.74M | -6.67M | -33.51M | -13.49M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.85M | -9.74M | -6.67M | -33.51M | -13.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.85M | -9.74M | -6.67M | -33.51M | -13.49M |
| EBIT | -7.67M | -7.04M | -5.84M | -5.42M | -6.38M |
| EBITDA | -7.09M | -6.48M | -5.35M | -4.86M | -6.04M |
| EPS Basic | -0.34 | -0.30 | -0.26 | -1.93 | -0.98 |
| Normalized Basic EPS | -0.15 | -0.14 | -0.14 | -0.19 | -0.29 |
| EPS Diluted | -0.34 | -0.30 | -0.26 | -1.93 | -0.98 |
| Normalized Diluted EPS | -0.15 | -0.14 | -0.14 | -0.19 | -0.29 |
| Average Basic Shares Outstanding | 32.03M | 32.02M | 25.69M | 17.38M | 13.71M |
| Average Diluted Shares Outstanding | 32.03M | 32.02M | 25.69M | 17.38M | 13.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |